+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Treatment Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 160 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797846
The global allergy treatment market size attained a value of USD 20.3 billion in 2022. The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2023-2031 to attain a value of USD 35.8 billion by 2031.

Allergy Treatment Market: Introduction

Allergy treatment refers to a range of therapies that are used to reduce the symptoms associated with allergies. Allergies are caused by an overactive immune response to a harmless substance, such as pollen or pet dander, and can result in a range of symptoms, including sneezing, itching, runny nose, and hives.

The most common treatments for allergies include medications, such as antihistamines, decongestants, and nasal corticosteroids, which work to reduce inflammation and relieve symptoms. Immunotherapy, also known as allergy shots or allergy drops, is another treatment option that involves gradually exposing patients to small amounts of the allergen that triggers their allergy symptoms, with the goal of building up their tolerance to the allergen over time.

In addition to these traditional treatments, there are a range of alternative therapies that are used to treat allergies, including acupuncture, herbal remedies, and homeopathy. These therapies are often used in conjunction with traditional treatments to provide additional relief from allergy symptoms.

The benefits of allergy treatment include relief from allergy symptoms, improved quality of life, and the prevention of more serious allergic reactions, such as anaphylaxis. Allergy treatment can also reduce the need for emergency medical care and the associated costs.

Allergy treatment is typically administered by allergists or immunologists in a clinical setting. Patients undergoing allergy treatment require close monitoring for potential side effects, particularly with immunotherapy, which can cause allergic reactions.

In summary, allergy treatment refers to a range of therapies that are used to reduce the symptoms associated with allergies. These treatments include medications, immunotherapy, and alternative therapies, and are typically administered by allergists or immunologists in a clinical setting. The benefits of allergy treatment include relief from allergy symptoms, improved quality of life, and the prevention of more serious allergic reactions. Allergy treatment is a long-term treatment option that requires close monitoring for potential side effects.

Allergy Epidemiology
The prevalence of allergies is increasing globally, leading to a rise in the demand for allergy treatment. Allergies affect individuals of all ages and genders and can be triggered by a variety of environmental factors and lifestyle habits.

Based on prevalence, the allergy treatment market is segmented into seasonal allergies, perennial allergies, food allergies, and others. Seasonal allergies are the most common type of allergy, with a high prevalence of allergic rhinitis and hay fever during the spring and fall months. Perennial allergies, such as allergies to pet dander and dust mites, are also prevalent throughout the year. Food allergies are another common type of allergy, affecting individuals of all ages and leading to potentially life-threatening reactions in some cases.

Based on age, the allergy treatment market is divided into children and adults. Allergies can develop at any age, with many individuals experiencing their first allergy symptoms during childhood. Children are a significant market for allergy treatment, as early intervention with treatment can prevent the development of asthma in children with allergies.

Based on gender, the allergy treatment market is segmented into male and female. Allergies affect individuals of all genders, with certain types of allergies, such as food allergies, being more prevalent in females.

Based on lifestyle habits, the allergy treatment market is divided into urban and rural populations. Urban populations are more likely to experience allergies, with exposure to air pollution and other environmental factors contributing to the development of allergies.

In summary, the allergy treatment market is segmented based on prevalence, age, gender, and lifestyle habits. Allergies affect individuals of all ages and genders and can be triggered by a variety of environmental factors and lifestyle habits. The allergy treatment market is expected to grow in response to the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments.

Allergy Treatment Market Segmentations

The market can be categorised into product type, treatment, route of administration, end user, and region.

Market Breakup by Type

  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Others

Market Breakup by Treatment

  • Anti-Allergy Drugs
  • Antihistamine
  • Corticosteroids
  • Decongestants
  • Other Drugs
  • Immunotherapy
  • Sub-Cutaneous Immunotherapy (SCIT)
  • Sub-Lingual Immunotherapy (SLIT)

Market Breakup by Route of Administration

  • Oral
  • Inhalation
  • Intranasal
  • Others

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Allergy Treatment Market Scenario

The global market for allergy treatment is growing rapidly, driven by the increasing prevalence of allergies and the development of new and innovative treatments. Allergies affect millions of people worldwide, leading to a significant burden on healthcare systems and a reduced quality of life for those affected.

The market for allergy treatment is highly competitive, with many players offering a wide range of products to cater to the diverse needs of healthcare providers and patients. The market is segmented based on product type, allergy type, distribution channel, and geography.

Based on product type, the market is divided into medications, immunotherapy, and alternative therapies. Medications are the largest segment of the market, with a high demand for antihistamines, decongestants, and nasal corticosteroids. Immunotherapy, also known as allergy shots or allergy drops, is another important segment of the market, particularly for patients with moderate to severe allergy symptoms that are not effectively controlled with medications.

Based on allergy type, the market is divided into seasonal allergies, perennial allergies, and food allergies. Seasonal allergies are the largest segment of the market, driven by the high prevalence of allergic rhinitis and hay fever during the spring and fall months.

Based on distribution channel, the market is divided into hospitals, specialty clinics, and pharmacies. Specialty clinics are the largest distribution channel segment of the market, owing to the specialized care required for allergy treatment and the growing demand for immunotherapy.

The market for allergy treatment is expected to continue to grow at a steady pace, driven by the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.

Overall, the market for allergy treatment is expected to continue to grow, driven by the increasing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.

Key Players in the Global Allergy Treatment Market

The report gives an in-depth analysis of the key players involved in the allergy treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • AbbVie Inc
  • Sanofi S.A
  • Johnson & Johnson Services, Inc
  • LETI Pharma, S.L.U
  • GlaxoSmithKline Plc
  • Zenomed Healthcare Private Limited
  • F. Hoffmann-La Roche AG
  • Cadila Pharmaceuticals
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • Akorn, Incorporated
  • Prestige Consumer Healthcare Inc
  • Astellas Pharma Inc
  • Eli Lilly and Company
  • Almirall, S.A

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Allergy Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Allergy Treatment Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Allergy Treatment Epidemiology (2016-2031)
5.3 Europe Allergy Epidemiology (2016-2031)
5.4 Asia-Pacific Allergy Epidemiology (2016-2031)
5.5 Latin America Allergy Epidemiology (2016-2031)
5.6 Middle East & Africa Allergy Epidemiology (2016-2031)
6 Global Allergy Treatment Market Overview
6.1 Global Allergy Treatment Market Historical Value (2016-2022)
6.2 Global Allergy Treatment Market Forecast Value (2023-2031)
7 Global Allergy Treatment Market Landscape
7.1 Allergy Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Allergy Treatment: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Treatment
7.2.3 Analysis by Route of Administration
7.2.4 Analysis by End User
8 Allergy Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Allergy Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Allergy Treatment Market Segmentation
11.1 Global Allergy Treatment Market by Type
11.1.1 Market Overview
11.1.2 Eye Allergy
11.1.3 Rhinitis
11.1.4 Asthma
11.1.5 Skin Allergy
11.1.6 Food Allergies
11.1.7 Others
11.2 Global Allergy Treatment Market by Treatment
11.2.1 Market Overview
11.2.2 Anti-Allergy Drugs
11.2.2.1 Antihistamine
11.2.2.2 Corticosteroids
11.2.2.3 Decongestants
11.2.2.4 Other Drugs
11.2.3 Immunotherapy
11.2.3.1 Sub-Cutaneous Immunotherapy (SCIT)
11.2.3.2 Sub-Lingual Immunotherapy (SLIT)
11.3 Global Allergy Treatment Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Inhalation
11.3.4 Intranasal
11.3.5 Others
11.4 Global Allergy Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Homecare
11.4.5 Others
11.5 Global Allergy Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Allergy Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Allergy Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Allergy Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Allergy Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Allergy Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 AbbVie Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Sanofi S.A.
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Johnson & Johnson Services, Inc.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 LETI Pharma, S.L.U.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 GlaxoSmithKline Plc.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Zenomed Healthcare Private Limited
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 F. Hoffmann-La Roche AG
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Cadila Pharmaceuticals
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Bayer AG
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Teva Pharmaceutical Industries Ltd.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Akorn, Incorporated
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Prestige Consumer Healthcare Inc.
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Astellas Pharma Inc.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Eli Lilly and Company
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 Almirall, S.A
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
24 Allergy Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Abbvie Inc.
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • Leti Pharma, S.L.U.
  • GlaxoSmithKline plc.
  • Zenomed Healthcare Private Limited
  • F. Hoffmann-La Roche AG
  • Cadila Pharmaceuticals
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Akorn, Incorporated
  • Prestige Consumer Healthcare Inc.
  • Astellas Pharma Inc.
  • Eli Lilly and Company
  • Almirall, S.A

Methodology

Loading
LOADING...

Table Information